A natural product telomerase activator as part of a health maintenance program: Metabolic and cardiovascular response

Rejuvenation Research

Volumn 16, Issue 5, 2013, Pages 386-395

  Harley, Calvin B ^a   Liu, Weimin ^b   Flom, Peter L ^a   Raffaele, Joseph M ^c  

^a TA Sciences   (United States)

^b TA Sciences   (United States)

^c PhysioAge Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHOLESTEROL; ENZYME ACTIVATOR; FOLIC ACID; GLUCOSE; HOMOCYSTEINE; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; MULTIVITAMIN; NITRIC OXIDE; PRASTERONE SULFATE; TA 65; TELOMERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BONE DENSITY; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CYTOTOXIC T LYMPHOCYTE; DIASTOLIC BLOOD PRESSURE; DIET; ENDOTHELIUM CELL; EXERCISE; FEMALE; FOLIC ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GRANULOCYTE; HEALTH PROGRAM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METABOLISM; OSTEOPOROSIS; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PLACEBO EFFECT; PRIORITY JOURNAL; SPINE; SYSTOLIC BLOOD PRESSURE; TELOMERE;

AGING; BIOLOGICAL MARKERS; BIOLOGICAL PRODUCTS; BLOOD GLUCOSE; BLOOD PRESSURE; BONE DENSITY; CARDIOVASCULAR SYSTEM; CHOLESTEROL; ENZYME ACTIVATORS; FEMALE; HEALTH; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTILEVEL ANALYSIS; TELOMERASE; VITAMINS;

EID: 84886018077     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2013.1430     Document Type: Article

References (51)

1. Harley CB, Liu W, Blasco M, Vera E, Andrews WH, Briggs LA, Raffaele JM. A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res 2011;14:45-56.
2. Lin J, Epel E, Blackburn E. Telomeres and lifestyle factors: Roles in cellular aging. Mutat Res 2012;730:85-89.
3. Kropski JA, Lawson WE, Young LR, Blackwell TS. Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis. Disease Models Mech 2013;6:9-17.
4. Aubert G, Baerlocher GM, Vulto I, Poon SS, Lansdorp PM. Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes. PLoS Genet 2012;8:e1002696.
5. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460.
6. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114-10118.
7. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994;91:9857-9860. (Pubitemid 24311907)
8. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D, Harley CB. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993;52:661-667. (Pubitemid 23310132)
9. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11: 1921-1929.
10. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994;91:2900-2904. (Pubitemid 24130141)
11. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994; 68:3410-3414. (Pubitemid 24129794)
12. Perera SA, Maser RS, Xia H, McNamara K, Protopopov A, Chen L, Hezel AF, Kim CF, Bronson RT, Castrillon DH, et al. Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancer. Carcinogenesis 2008;29:747-753. (Pubitemid 351494161)
13. Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis 2010;31:9-18.
14. Sahin E, Depinho RA. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 2010;464:520-528.
15. de Lange T. How telomeres solve the end-protection problem. Science 2009;326:948-952.
16. Ridker PM, MacFadyen J, Cressman M, Glynn RJ. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol 2010;55: 1266-1273.
17. Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: The path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006;12: 1133-1138. (Pubitemid 44527346)
18. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-352. (Pubitemid 28063364)
19. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage, M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 1999; 21:111-114.
20. Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, Sahin E, Kost-Alimova M, Protopopov A, Cadinanos J, et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011;469:102-106.
21. Bernardes de Jesus B, Vera E, Schneeberger K, Tejera AM, Ayuso E, Bosch F, Blasco MA. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med 2012;4:691-704.
22. Bernardes de Jesus BB, Schneeberger K, Vera E, Tejera, A, Harley CB, Blasco MA. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell 2011;10:604-621.
23. Svenson U, Nordfjall K, Baird D, Roger L, Osterman P, Hellenius ML, Roos G. Blood cell telomere length is a dynamic feature. PloS One 2011;6:e21485.
24. Epel ES, Merkin SS, Cawthon R, Blackburn EH, Adler NE, Pletcher MJ, Seeman TE. The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging 2009;1:81-88.
25. Jacobs TL, Epel ES, Lin J, Blackburn EH, Wolkowitz OM, Bridwell DA, Zanesco AP, Aichele SR, Sahdra BK, MacLean KA, et al. Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology 2011;36:664-681.
26. Farzaneh-Far R, Lin J, Epel ES, Harris WS, Blackburn EH, Whooley MA. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 2010;303:250-257.
27. Kiecolt-Glaser JK, Epel ES, Belury MA, Andridge R, Lin J, Glaser R, Malarkey WB, Hwang BS, Blackburn E. Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial. Brain Behav Immun 2013; 28:16-24.
28. Ho RT, Chan JS, Wang CW, Lau BW, So KF, Yuen LP, Sham JS, Chan CL. A randomized controlled trial of qigong exercise on fatigue symptoms, functioning, and telomerase activity in persons with chronic fatigue or chronic fatigue syndrome. Ann Behav Med 2012;44:160-170.
29. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Reus VI, Rosser R, Burke H, Compagnone M, Nelson JC, Dhabhar FS, et al. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry 2012;17:164-172.
30. Lavretsky H, Epel ES, Siddarth P, Nazarian N, Cyr NS, Khalsa DS, Lin J, Blackburn E, Irwin MR. A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: Effects on mental health, cognition, and telomerase activity. Int J Geriatr Psychiatry 2013;28: 57-65.
31. Epel E. How "reversible" is telomeric aging? Cancer Prev Res 2012;5:1163-1168.
32. Fauce SR, Jamieson BD, Chin AC, Mitsuyasu RT, Parish ST, Ng HL, Kitchen CM, Yang OO, Harley CB, Effros RB. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J Immunol 2008; 181:7400-7406.
33. Yung LY, Lam WS, Ho MK, Hu Y, Ip FC, Pang H, Chin AC, Harley CB, Ip NY, Wong YH. Astragaloside IV and cycloastragenol stimulate the phosphorylation of extracellular signal-regulated protein kinase in multiple cell types. Planta Medica 2012;78:115-121.
34. Zhu J, Lee S, Ho MK, Hu Y, Pang H, Ip FC, Chin AC, Harley CB, Ip NY, Wong YH. In vitro intestinal absorption and firstpass intestinal and hepatic metabolism of cycloastragenol, a potent small molecule telomerase activator. Drug Metab Pharmacokinet 2010;25:477-486.
35. Cohen S, Janicki-Deverts D, Turner RB, Casselbrant ML, Li-Korotky HS, Epel ES, Doyle WJ. Association between telomere length and experimentally induced upper respiratory viral infection in healthy adults. JAMA 2013;309: 699-705.
36. Sehl ME, Yates FE. Kinetics of human aging: I. Rates of senescence between ages 30 and 70 years in healthy people. J Gerontol A Biol Sci Med Sci 2001;56:B198-B208. (Pubitemid 32381798)
37. Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011;470:359-365.
38. Haendeler J, Drose S, Buchner N, Jakob S, Altschmied J, Goy C, Spyridopoulos I, Zeiher AM, Brandt U, Dimmeler S. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler Thromb Vasc Biol 2009;29:929-935.
39. Rentoukas E, Tsarouhas K, Kaplanis I, Korou E, Nikolaou M, Marathonitis G, Kokkinou S, Haliassos A, Mamalaki A, Kouretas D, et al. Connection between telomerase activity in PBMC and markers of inflammation and endothelial dysfunction in patients with metabolic syndrome. PloS One 2012;7:e35739.
40. Berns MA, de Vries JH, Katan MB. Determinants of the increase of serum cholesterol with age: a longitudinal study. Int J Epidemiol 1988;17:789-796. (Pubitemid 19042019)
41. Volpato S, Zuliani G, Guralnik JM, Palmieri E, Fellin R. The inverse association between age and cholesterol level among older patients: The role of poor health status. Gerontology 2001;47:36-45. (Pubitemid 32215815)
42. Kelley GA, Kelley KS, Roberts S, Haskell W. Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: A meta-analysis of randomized controlled trials. Clin Nutr 2012;31:156-167.
43. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, Magbanua MJ, Marlin R, Yglecias L, Carroll PR, et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. The Lancet Oncol 2008;9:1048-1057.
44. Franklin SS., Gustin WT, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997;96:308-315. (Pubitemid 27298437)
45. Benetos A, Gardner JP, Kimura M, Labat C, Nzietchueng R, Dousset B, Zannad F, Lacolley P, Aviv A. Aldosterone and telomere length in white blood cells. J Gerontol A, Biol Sci Med Sci 2005;60:1593-1596. (Pubitemid 43146468)
46. Graham IM, O'Callaghan P. Vitamins, homocysteine and cardiovascular risk. Cardiovasc Drugs Ther 2002;16:383-389. (Pubitemid 36255738)
47. Ulrich CM, Potter JD. Folate supplementation: Too much of a good thing? Cancer Epidemiol Biomarkers Prev 2006;15: 189-193. (Pubitemid 43342163)
48. Sauer J, Mason JB, Choi SW. Too much folate: A risk factor for cancer and cardiovascular disease? Curr Opin Clin Nutr Metabol Care 2009;12:30-36.
49. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-676. (Pubitemid 27375473)
50. Graham LS, Tintut Y, Parhami F, Kitchen CM, Ivanov Y, Tetradis S, Effros RB. Bone density and hyperlipidemia: The T-lymphocyte connection. J Bone Min Res 2010;25:2460-2469.
51. Bernardes de Jesus B, Schneeberger K, Vera E, Tejera A, Harley CB, Blasco MA. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell 2011;10:604-621.